Uralyt


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 19.8%
Hyperuricaemia 19.0%
Chronic Myeloid Leukaemia 10.3%
Dizziness 10.3%
Constipation 5.2%
Nausea 5.2%
Anaemia 3.4%
Breast Cancer 3.4%
Hyperlipidaemia 3.4%
Arteriosclerosis 2.6%
Gastric Ulcer 2.6%
Gout 2.6%
Hepatitis C 2.6%
Rhinitis Allergic 2.6%
Epilepsy 1.7%
Hypothyroidism 1.7%
Alopecia 0.9%
Chronic Hepatitis C 0.9%
Insomnia 0.9%
Oral Discomfort 0.9%
Toxic Epidermal Necrolysis 23.8%
Hepatitis 14.3%
Hyponatraemia 9.5%
Liver Disorder 9.5%
Osteonecrosis 9.5%
Thyroiditis 9.5%
Altered State Of Consciousness 4.8%
Blood Pressure Decreased 4.8%
Platelet Count Decreased 4.8%
Rash 4.8%
White Blood Cell Count Decreased 4.8%
Concomitant
Product Used For Unknown Indication 12.4%
Hypertension 11.8%
Rheumatoid Arthritis 11.3%
Hyperuricaemia 9.6%
Prophylaxis 9.5%
Chronic Myeloid Leukaemia 7.9%
Drug Use For Unknown Indication 5.8%
Pneumonia 5.7%
Multiple Myeloma 4.3%
Hepatitis C 2.9%
Asthma 2.8%
Gout 2.7%
Hyperlipidaemia 2.4%
Nephrogenic Anaemia 2.2%
Diabetes Mellitus 2.1%
Acute Lymphocytic Leukaemia 1.4%
Rhinitis Allergic 1.4%
Chronic Hepatitis C 1.3%
Prostate Cancer Stage Iv 1.3%
Bipolar Ii Disorder 1.3%
White Blood Cell Count Decreased 13.3%
Electrocardiogram Qt Prolonged 9.1%
Interstitial Lung Disease 8.4%
Hyperkalaemia 7.7%
Pneumonia 5.6%
Sepsis 5.6%
Thrombocytopenia 5.6%
Cerebral Haemorrhage 4.9%
Hepatic Function Abnormal 4.9%
Lipase Increased 4.2%
Renal Disorder 4.2%
Rhabdomyolysis 4.2%
Febrile Neutropenia 3.5%
Glycosylated Haemoglobin Increased 2.8%
Liver Disorder 2.8%
Loss Of Consciousness 2.8%
Melaena 2.8%
Nasopharyngitis 2.8%
Stomatitis 2.8%
Conjunctival Hyperaemia 2.1%

Drug Data